Anxious Personality and Breast Cancer: Possible Negative Impact on Quality of Life After Breast-Conserving Therapy

van der Steeg, Alida F. W.; Vries, Jolanda De; Roukema, Jan A.
July 2010
World Journal of Surgery;Jul2010, Vol. 34 Issue 7, p1453
Academic Journal
Quality of Life (QoL) is an important outcome measure in oncology. To assess the influence of surgical treatment and personality on QoL in women with breast cancer, a longitudinal prospective cohort study was done. Women ( n = 222) completed questionnaires concerning QoL (WHOQOL 100) and personality (NEO-FFI and STAI) prior to the diagnosis of breast cancer and 1, 3, 6, and 12 months after diagnosis and treatment. One hundred five women were treated with breast-conserving therapy (BCT) and 117 women underwent mastectomy (MTC). The two treatment groups did not differ on overall QoL. At all measurement times the influence of trait anxiety on overall QoL was substantial in the BCT group. Women with a high score on trait anxiety were seven times more likely to have a low overall QoL 1 year after BCT. In the MTC group overall QoL was influenced mainly by neuroticism. Personality, especially trait anxiety and neuroticism, determined patients’ overall QoL scores. Women with an anxious personality fared worse concerning QoL after breast conserving therapy.


Related Articles

  • Calidad de vida y factores asociados en mujeres con cáncer de mama en Antioquia, Colombia. Zapata, Carolina Salas; Romero, Hugo Grisales // Pan American Journal of Public Health;Jul2010, Vol. 28 Issue 1, p9 

    Objective. To determine the quality of life and some associated factors in women diagnosed with breast cancer enrolled in cancer treatment programs in a Colombian province. Methods. In a cross-sectional study, the WHOQOL BREF domains related to the quality of life of 220 women with breast cancer...

  • Upper-body morbidity following breast cancer treatment is common, may persist longer-term and adversely influences quality of life. Hayes, Sandra C.; Rye, Sheree; Battistutta, Diana; DiSipio, Tracey; Newman, Beth // Health & Quality of Life Outcomes;2010, Vol. 8, p92 

    Background: Impairments in upper-body function (UBF) are common following breast cancer. However, the relationship between arm morbidity and quality of life (QoL) remains unclear. This investigation uses longitudinal data to describe UBF in a population-based sample of women with breast cancer...

  • Symptoms after breast cancer treatment: are they influenced by patient characteristics? Yoon, Jean; Malin, Jennifer L.; May Lin Tao; Tisnado, Diana M.; Adams, John L.; Timmer, Martha J.; Ganz, Patricia A.; Kahn, Katherine L. // Breast Cancer Research & Treatment;Mar2008, Vol. 108 Issue 2, p153 

    Purpose: This study examines the burden of symptoms by treatment type and patient characteristics in a population-based sample of newly diagnosed breast cancer patients. Methods: Using the Los Angeles County SEER Registry Rapid Case Ascertainment, we identified a cohort of breast cancer patients...

  • Acceptance of the illness and the quality of life of patients with breast cancer. KAMIŃSKA, MARZENA; CISZEWSKI, TOMASZ; BRONIKOWSKA, AGNIESZKA; FERAŃSKA, MARIA; PAWLAK-WARSZAWSKA, AGNIESZKA; PAŚNIK, ELWIRA // Polish Journal of Public Health;2014, Vol. 124 Issue 1, p5 

    Introduction. Breast cancer is the most frequent cancer diagnosed in women. Its treatment is a combined therapy and the sequence and time are established according to the accepted standards in Poland. Consequences posed by this disease include disorder in the physical, mental and social spheres...

  • Menopausal symptoms after breast cancer treatment and effects on quality of life. Gupta, P; Majumder, K; Palin, S; Sturdee, D // Journal of the British Menopause Society;2004 Supplement, Vol. 10, p13 

    An abstract of the article "Menopausal symptoms after breast cancer treatment and effects on quality of life," by P. Gupta, K. Majumder, S. Palin, and D. Sturdee is presented. It presents a study which seeks to promote knowledge on the treatment of menopausal symptoms and their effects. The...

  • Deciding on Drug Therapies.  // Mayo Clinic Guide to Women's Cancers;2005, p249 

    This section relates several factors that should be considered before using various drug therapies in the treatment of metastatic breast cancer. The following questions should be addressed: goal of the therapy; response rate with the therapy; Response duration of the therapy; evidence that the...

  • Psychological welfare of patients with breast cancer. Fallowfield, L. J.; Baum, M. // Journal of the Royal Society of Medicine;Jan1989, Vol. 82 Issue 1, p4 

    The author reflects on the psychological welfare of patients with breast cancer. The author stressed that the role of cytotoxic chemotherapy in breast cancer remains a controversial issue. He pointed that there has been an increasing awareness by health professionals of the psychosocial havoc...

  • Analysis of Existing Research Doesn't Support Withholding Estrogen Therapy After Low Stage Breast Cancer.  // Ascribe Newswire: Medicine;2/13/2003, p1 

    A study conducted by researcher Linda Meurer, associate professor of family & community medicine and her colleagues does not support universal withholding of estrogen replacement therapy from well-informed women who have been diagnosed with low-stage breast cancer. Results of their analysis...

  • SISTERS FOR LIFE. Williams, Daniel // Time International (South Pacific Edition);11/1/2004, Issue 43, p48 

    The article focuses on the Supportive-Expressive Group Therapy (SECT) trial for women having breast cancer initiated by a group of women called the Thursday Girls in Melbourne, Victoria. In the seven-year trial of the SECT, the participants meet weekly to discuss their cancer, including their...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics